yourstate.us
21 U.S.C. § 360m

Accredited persons

United States · Title 21 — FOOD AND DRUGS · Status: effective

Get this as JSONEmbed this
Cite this
Citation
21 U.S.C. § 360m, Accredited persons, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/454286
Permanent ID
ys:prov:454286@1
SHA-256
fe0531ba8e2e8de0dfa03bc6b322b27243de85b21b0f0bc38fb686a422b9e712

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

Not later than 1 year after November 21, 1997, the Secretary shall, subject to paragraph (3), accredit persons for the purpose of reviewing reports submitted under section 360(k) of this title and making recommendations to the Secretary regarding the initial classification of devices under section 360c(f)(1) of this title. In making a recommendation to the Secretary under paragraph (1), an accredited person shall notify the Secretary in writing of the reasons for the recommendation. Not later than 30 days after the date on which the Secretary is notified under subparagraph (A) by an accredited person with respect to a recommendation of an initial classification of a device, the Secretary shall make a determination with respect to the initial classification. The Secretary may change the initial classification under section 360c(f)(1) of this title that is recommended under paragraph (1) by an accredited person, and in such case shall provide to such person, and the person who submitted the report under section 360(k) of this title for the device, a statement explaining in detail the reasons for the change. An accredited person may not be used to perform a review of— The Secretary shall— issue draft guidance on the factors the Secretary will use in determining whether a class I or class II device type, or subset of such device types, is eligible for review by an accredited person, including— Until the date on which the updated list is designated and posted in accordance with subparagraph (B)(iii), the list in effect on August 18, 2017, shall be in effect. The Secretary shall provide for such accreditation through programs administered by the Food and Drug Administration, other government agencies, or by other qualified nongovernment organizations. Not later than 180 days after November 21, 1997, the Secretary shall establish and publish in the Federal Register criteria to accredit or deny accreditation to persons who request to perform the duties specified in subsection (a). The Secretary shall respond to a request for accreditation within 60 days of the receipt of the request. The accreditation of such person shall specify the particular activities under subsection (a) for which such person is accredited. The Secretary may suspend or withdraw accreditation of any person accredited under this paragraph, after providing notice and an opportunity for an informal hearing, when such person is substantially not in compliance with the requirements of this section or poses a threat to public health or fails to act in a manner that is consistent with the purposes of this section. To ensure that persons accredited under this section will continue to meet the standards of accreditation, the Secretary shall— Subject to suspension or withdrawal under subparagraph (B), any accreditation under this section shall be valid for a period of 3 years after its issuance. Upon the submission of a request by an accredited person for reaccreditation under this section, the Secretary shall approve or deny such request not later than 60 days after receipt of the request. Not later than 120 days after July 9, 2012, the Secretary shall establish and publish in the Federal Register criteria to reaccredit or deny reaccreditation to persons under this section. The reaccreditation of persons under this section shall specify the particular activities under subsection (a), and the devices, for which such persons are reaccredited. An accredited person shall, at a minimum, meet the following requirements: Such person shall agree, at a minimum, to include in its request for accreditation a commitment to, at the time of accreditation, and at any time it is performing any review pursuant to this section— The Secretary shall provide each person who chooses to use an accredited person to receive a section 360(k) of this title report a panel of at least two or more accredited persons from which the regulated person may select one for a specific regulatory function. Compensation for an accredited person shall be determined by agreement between the accredited person and the person who engages the services of the accredited person, and shall be paid by the person who engages such services. The authority provided by this section terminates on October 1, 2027.

Legislative history

The public laws that enacted or amended this section. Tallies are for the whole bill as it passed each chamber — often an omnibus covering far more than this provision — not a vote on this section alone.

  • Enacted byPub. L. 105-115(S. 830)1997-11-21
    Food and Drug Administration Modernization Act of 1997
    House: no recorded tallySenate: 98–2
  • Amended byPub. L. 107-250(H.R. 5651)2002-10-26
    Medical Device User Fee and Modernization Act of 2002
    House: no recorded tallySenate: no recorded tally
  • Amended byPub. L. 110-85(H.R. 3580)2007-09-27
    Food and Drug Administration Amendments Act of 2007
    House: 405–7Senate: no recorded tally
  • Amended byPub. L. 111-31(H.R. 1256)2009-06-22
    To protect the public health by providing the Food and Drug Administration with certain authority to regulate tobacco products, to amend title 5, United States Code, to make certain modifications in the Thrift Savings Plan, the Civil Service Retirement System, and the Federal Employees' Retirement System, and for other purposes.
  • Amended byPub. L. 112-144(S. 3187)2012-07-09
    Food and Drug Administration Safety and Innovation Act
    House: no recorded tallySenate: 96–1
  • Amended byPub. L. 114-255(H.R. 34)2016-12-13
    21st Century Cures Act
    House: no recorded tallySenate: no recorded tally
  • Amended byPub. L. 115-52(H.R. 2430)2017-08-18
    FDA Reauthorization Act of 2017
    House: no recorded tallySenate: 94–1
  • Amended byPub. L. 117-180(H.R. 6833)2022-09-30
    Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
  • Amended byPub. L. 117-229(H.R. 1437)2022-12-16
    Further Continuing Appropriations and Extensions Act, 2023
    House: 224–201Senate: no recorded tally
  • Amended byPub. L. 117-328(H.R. 2617)2022-12-29
    Consolidated Appropriations Act, 2023
    House: 225–201Senate: no recorded tally